Does an undescended testicle (cryptorchidism) increase the risk of testicular cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Undescended Testicle Significantly Increases Risk of Testicular Cancer

Yes, cryptorchidism (undescended testicle) significantly increases the risk of testicular cancer, with men having a 3.6-7.4 times higher risk compared to the general population, and approximately 2-6% of men with a history of cryptorchidism will develop testicular cancer. 1

Risk Magnitude and Distribution

The increased risk of testicular cancer varies based on several factors:

  • Overall risk increase: 3.6-7.4 times higher than general population 1
  • Ipsilateral vs. contralateral risk:
    • Undescended testis (ipsilateral): 6.33 times higher risk 2
    • Normal descended testis (contralateral): 1.74 times higher risk 2
  • Location of tumor development: In men with unilateral cryptorchidism who develop testicular cancer, approximately 79% of tumors occur in the previously undescended testis, while 21% occur in the contralateral normally descended testis 2

Risk Modifiers

Several factors affect the magnitude of cancer risk:

  • Age at surgical correction: The risk increases with delayed treatment
    • Treatment before age 13: Relative risk of 2.23 compared to general population
    • Treatment at age 13 or older: Relative risk of 5.40 3
  • Surgical correction status: Highest risk in men whose cryptorchid testis was never surgically corrected 4
  • Bilateral vs. unilateral: Both conditions increase risk, but bilateral cryptorchidism may carry higher risk

Clinical Management Implications

Based on this increased risk, the European Association of Urology and American Urological Association recommend:

  1. Early surgical intervention: Orchidopexy performed before puberty reduces the risk of testicular cancer, though risk remains elevated compared to men without cryptorchidism 1

  2. Adult management options:

    • For adults with unilateral undescended testis and normal contralateral testis: Orchidectomy may be offered to reduce cancer risk 1, 5
    • For adults with bilateral undescended testes or impaired contralateral function: Orchidopexy with simultaneous testicular biopsy to detect intratubular germ cell neoplasia 1, 5
  3. Surveillance recommendations:

    • Regular testicular self-examination after puberty 1
    • Men with cryptorchidism should be counseled about their increased cancer risk 1

Common Pitfalls and Caveats

  • Persistent risk after correction: Even with early orchidopexy, the risk of testicular cancer remains elevated compared to men without cryptorchidism 1
  • Contralateral risk: The normally descended testis in men with unilateral cryptorchidism still has a slightly elevated cancer risk (1.74 times higher) 2
  • Hormonal treatment ineffectiveness: Hormonal treatment is not recommended for cryptorchidism in postpubertal men 1
  • Fertility considerations: While this question focuses on cancer risk, it's worth noting that men with history of bilateral cryptorchidism have significantly reduced fertility (paternity rates of 35-53%) compared to those with unilateral cryptorchidism (who have near-normal fertility) 1, 5

Understanding this increased risk is essential for appropriate patient counseling, management decisions, and surveillance strategies in men with a history of cryptorchidism.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Age at surgery for undescended testis and risk of testicular cancer.

The New England journal of medicine, 2007

Guideline

Management of Adult Cryptorchidism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.